Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced it will present new clinical data from its OVERTURE ...

Charles River Laboratories International, Inc. and Valo Health, Inc. today announced the identification of an advanceable product candidate for the treatment of different forms of lupus and other ...

The man behind this project was determined to leave no stone unturned, so he’s really worked wonders in making this CX cafe ...

First4 6, 8, 3, 7 ELECTRON, MOSINVADER, NEREUS, UDERZO $1,588.20 ...

We read every piece of feedback, and take your input very seriously.